Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhaoke
- Development stage
- Unknown
- Lead developer
- Zhaoke Ophthalmology
- Administration
- Injection
01
Overview
Zhaoke is mentioned as an intervention in a randomized, double-blind, single-dose, parallel-parallelized phase I clinical study. This study compares TQB2709 injection with Zhaoke in healthy male volunteers to assess pharmacokinetics and safety similarity. The disease context for this comparison is Multiple Myeloma. However, specific details regarding the active ingredient, mechanism of action, or the primary developer/manufacturer of 'Zhaoke' as a drug for Multiple Myeloma could not be identified from available information. General searches for 'Zhaoke' primarily refer to 'Zhaoke Ophthalmology Limited', a company focused on ophthalmic pharmaceuticals, which is not associated with Multiple Myeloma treatments.
- Brand names
- Zhaoke
Beyond the preview
Go deeper on Zhaoke.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhaoke.